Search

everythinglearnresearchcommunity

for

Search:↓

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Fenugreek extract may help treat benign prostatic hyperplasia.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Dutasteride is approved to help manage prostate enlargement.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Finasteride and minoxidil work best together for hair loss.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.